COVID-SEROKLIR

Dead / Abandoned — Abandoned — failure to respond (as of 12 Apr 2022)

What this means for you

This application is over — abandoned 29 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90130724
Mark type
Stylized text
Filed
21 Aug 2020
Abandoned
29 Mar 2022
Attorney of record
Michelle A. Cooke

Goods and services

  • Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes for use in hospitals; Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens; Assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical and clinical purposes; Diagnostic reagents for serologic tests of infections for medical and clinical purposes; Diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of material, preparations, assays and reagents and also consisting of vessels, containers and implements for performing serological, molecular PCR, antigen and antibody detection tests, and used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Kits and components comprised of assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles for use in performing medical diagnostic testing for medical or veterinary use; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic test in the nature of medical diagnostic reagents and assays for testing of bodily fluids for antibodies for use in disease detection, namely, SARS-CoV-2, COVID-19, cancer, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical and clinical test kits comprised of assays, reagents, media, solutions, buffers and preparations for use in disease detection and monitoring of coronavirus, SARS-CoV-2 and COVID-19; Diagnostic preparations for medical and clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Preparations and substances for the diagnosis, prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19

Owner

Prosecution history

  • 12 Apr 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 12 Apr 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
  • 12 Apr 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 28 Sept 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 28 Sept 2021 — NON-FINAL ACTION E-MAILED
  • 28 Sept 2021 — NON-FINAL ACTION WRITTEN
  • 30 Aug 2021 — ASSIGNED TO EXAMINER
  • 27 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 26 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 26 Aug 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 06 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 06 Mar 2021 — NON-FINAL ACTION E-MAILED
  • 06 Mar 2021 — NON-FINAL ACTION WRITTEN
  • 22 Feb 2021 — ASSIGNED TO EXAMINER
  • 24 Sept 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Marksy